Envoy Medical, Inc.
COCH
$1.14
-$0.01-0.87%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.71% | -22.03% | -55.79% | -30.00% | 7.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.71% | -22.03% | -55.79% | -30.00% | 7.94% |
| Cost of Revenue | -4.49% | 47.71% | -32.91% | -1.06% | 51.23% |
| Gross Profit | 11.86% | -91.49% | 17.27% | -20.18% | -78.79% |
| SG&A Expenses | 16.55% | -10.33% | -45.08% | 46.28% | -6.46% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.63% | 4.25% | -33.03% | 45.17% | 8.30% |
| Operating Income | -4.49% | -4.57% | 32.71% | -46.94% | -8.30% |
| Income Before Tax | -44.16% | 20.29% | 5.66% | -481.32% | 70.20% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -44.16% | 20.29% | 5.66% | -481.32% | 70.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -44.16% | 20.29% | 5.66% | -481.32% | 70.20% |
| EBIT | -4.49% | -4.57% | 32.71% | -46.94% | -8.30% |
| EBITDA | -3.64% | -4.04% | 32.94% | -46.75% | -8.07% |
| EPS Basic | -13.66% | 28.77% | -40.99% | -381.14% | 78.18% |
| Normalized Basic EPS | -25.41% | 30.47% | -8.08% | 7.05% | 83.79% |
| EPS Diluted | -13.66% | 28.77% | -41.55% | -398.88% | 78.18% |
| Normalized Diluted EPS | -25.41% | 30.47% | -8.08% | -2.04% | 83.79% |
| Average Basic Shares Outstanding | 14.97% | 14.66% | -12.69% | 92.05% | 83.75% |
| Average Diluted Shares Outstanding | 14.97% | 14.66% | -12.69% | 74.91% | 83.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |